Microarray analysis of DNA damage repair gene expression profiles in cervical cancer cells radioresistant to 252Cf neutron and X-rays

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Qing, Yi ^a   Yang, Xue Qin ^a   Zhong, Zhao Yang ^a   Lei, Xin ^a   Xie, Jia Yin ^a   Li, Meng Xia ^a   Xiang, De Bing ^a   Li, Zeng Peng ^a   Yang, Zhen Zhou ^a   Wang, Ge ^a   Wang, Dong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALIFORNIUM 252;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIVISION; CLONOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG TARGETING; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; HELA CELL; HUMAN; HUMAN CELL; IONIZING RADIATION; MICROARRAY ANALYSIS; NEUTRON RADIATION; NUCLEOTIDE SEQUENCE; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; ULTRASTRUCTURE; UNINDEXED SEQUENCE; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING; X RAY; DNA MICROARRAY; GENE EXPRESSION REGULATION; METABOLISM; NEUTRON; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; DNA DAMAGE; DNA REPAIR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; NEUTRONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS; X-RAYS;

EID: 77950531914     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-71     Document Type: Article

References (41)

1. Pontén J, Adami HO, Bergström R, Dillner J, Friberg LG, Gustafsson L, Miller AB, Parkin DM, Sparén P, Trichopoulos D. Strategies for global control of cervical cancer. Int J Cancer 1995, 60:1-26. 10.1002/ijc.2910600102, 7814140.
2. Harima Y, Togashi A, Horikoshi K, Imamura M, Sougawa M, Sawada S, Tsunoda T, Nakamura Y, Katagiri T. Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys 2004, 60:237-248.
3. Ma BB, Bristow RG, Kim J, Siu LL. Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents. J Clin Oncol 2003, 21:2760-2776. 10.1200/JCO.2003.10.044, 12860956.
4. Withers HR. Biological basis for high-LET radiotherapy. Radiology 1973, 108:131-137.
5. Marjina LA, Kiseleva MV, Chekhonadsky VN. Radiation treatment of the cervix uteri cancer with usage of high activity 252Cf sources. Radiother Oncol 2002, 63(Suppl):s21.
6. Tacev T, Ptácková B, Strnad V. Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study. Strahlenther Onkol 2003, 179:377-384. 10.1007/s00066-003-1006-3, 12789463.
7. Elkind MM. DNA damage and cell killing. Cause and effect?. Cancer 1985, 56:2351-2363. 10.1002/1097-0142(19851115)56:10<2351::AID-CNCR2820561002>3.0.CO;2-H, 4042069.
8. Thompson LH, Brookman KW, Dillehay LE, Carrano AV, Mazrimas JA, Mooney CL, Minkler JL. A CHO-cell strain having hypersensitivity to mutagens, a defect in DNA strand-break repair, and an extraordinary baseline frequency of sister-chromatid exchange. Mutat Res 1982, 95:427-440.
9. Kelland LR, Edwards SM, Steel GG. Induction and rejoining of DNA double-strand breaks in human cervix carcinoma cell lines of differing radiosensitivity. Radiat Res 1988, 116:526-538. 10.2307/3577394, 3205912.
10. Schwartz JL, Rotmensch J, Giovanazzi S, Cohen MB, Weichselbaum RR. Faster repair of DNA double-strand breaks in radioresistant human tumor cells. Int J Radiat Oncol Biol Phys 1988, 15:907-912.
11. Russell J, Wheldon TE, Stanton P. A radioresistant variant derived from a human neuroblastoma cell line is less prone to radiation-induced apoptosis. Cancer Res 1995, 55:4915-4921.
12. Dahlberg WK, Azzam EI, Yu Y, Little JB. Response of human tumor cells of varying radiosensitivity and radiocurability to fractionated irradiation. Cancer Res 1999, 59:5365-69.
13. Pearce AG, Segura TM, Rintala AC, Rintala-Maki ND, Lee H. The generation and characterization of a radiation-resistant model system to study radioresistance in human breast cancer cells. Radiat Res 2001, 156:739-750. 10.1667/0033-7587(2001)156[0739:TGACOA]2.0.CO;2, 11741498.
14. Wei K, Kodym R, Jin C. Radioresistant cell strain of human fibrosarcoma cells obtained after long-term exposure to x-rays. Radiat Environ Biophys 1998, 37:133-137. 10.1007/s004110050106, 9728747.
15. Ewing D. Production of radiation-resistant E. coli strains by daily X-irradiation. Int J Radiat Biol 1997, 71:253-258. 10.1080/095530097144120, 9134014.
16. Wazer DE, Joyce M, Jung L, Band V. Alterations in growth phenotype and radiosensitivity after fractionated irradiation of breast carcinoma cells from a single patient. Int J Radiat Oncol Biol Phys 1993, 26:81-88.
17. Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Haraguchi N, Inoue H, Murayama S, Mori M. Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation. Int J Oncol 2006, 28:705-713.
18. Fukuda K, Sakakura C, Miyagawa K, Kuriu Y, Kin S, Nakase Y, Hagiwara A, Mitsufuji S, Okazaki Y, Hayashizaki Y, Yamagishi H. Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation. Br J Cancer 2004, 91:1543-1550. 10.1038/sj.bjc.6602187, 2409931, 15365572.
19. Chang JT, Chan SH, Lin CY, Lin TY, Wang HM, Liao CT, Wang TH, Lee LY, Cheng AJ. Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol Cancer Ther 2007, 6:2271-2279. 10.1158/1535-7163.MCT-06-0801, 17671084.
20. Maity A, Kao GD, Muschel RJ, McKenna WG. Potential molecular targets for manipulating the radiation response. Int J Radiat Oncol Biol Phys 1997, 37:639-53.
21. Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 2004, 59:928-942. 10.1016/j.ijrobp.2004.03.005, 15234026.
22. Iliakis G, Metzger L, Muschel RJ, McKenna WG. Induction and repair of DNA double strand breaks in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc. Cancer Res 1990, 50:6575-6579.
23. Verheij M, Bartelink H. Radiation-induced apoptosis. Cell Tissue Res 2000, 301:133-142. 10.1007/s004410000188, 10928286.
24. Meyn RE, Stephens LC, Milas L. Programmed cell death and radioresistance. Cancer Metastasis Rev 1996, 15:119-131. 10.1007/BF00049491, 8842483.
25. Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 2006, 6:702-713. 10.1038/nrc1950, 16929324.
26. Kitahara O, Katagiri T, Tsunoda T, Harima Y, Nakamura Y. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia 2002, 4:295-303. 10.1038/sj.neo.7900251, 1531706, 12082545.
27. Wong YF, Selvanayagam ZE, Wei N, Porter J, Vittal R, Hu R, Lin Y, Liao J, Shih JW, Cheung TH, Lo KW, Yim SF, Yip SK, Ngong DT, Siu N, Chan LK, Chan CS, Kong T, Kutlina E, McKinnon RD, Denhardt DT, Chin KV, Chung TK. Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res 2003, 9:5486-5492.
28. Harima Y, Togashi A, Horikoshi K, Imamura M, Sougawa M, Sawada S, Tsunoda T, Nakamura Y, Katagiri T. Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys 2004, 60:237-248.
29. Chung YM, Kim BG, Park CS, Huh SJ, Kim J, Park JK, Cho SM, Kim BS, Kim JS, Yoo YD, Bae DS. Increased expression of ICAM-3 is associated with radiation resistance in cervical cancer. Int J Cancer 2005, 117:194-201. 10.1002/ijc.21180, 15880373.
30. Wong YF, Sahota DS, Cheung TH, Lo KW, Yim SF, Chung TK, Chang AM, Smith DI. Gene expression pattern associated with radiotherapy sensitivity in cervical cancer. Cancer J 2006, 12:189-193. 10.1097/00130404-200605000-00006, 16803676.
31. Harima Y, Sawada S, Miyazaki Y, Kin K, Ishihara H, Imamura M, Sougawa M, Shikata N, Ohnishi T. Expression of Ku80 in cervical cancer correlates with response to radiotherapy and survival. Am J Clin Oncol 2003, 26:e80-85. 10.1097/00000421-200308000-00028, 12902903.
32. Fornace AJ, Amundson SA, Bittner M, Myers TG, Meltzer P, Weinsten JN, Trent J. The complexity of radiation stress responses: analysis by informatics and functional genomics approaches. Gene Expr 1999, 7:387-400.
33. Maity A, McKenna WG, Muschel RJ. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother Oncol 1994, 31:1-13. 10.1016/0167-8140(94)90408-1, 8041894.
34. Rouault JP, Falette N, Guéhenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C, Puisieux A. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 1996, 14:482-486. 10.1038/ng1296-482, 8944033.
35. Wang G, Zhang XR, Hu L, Wang J, Leng ER, Fang DC, Yang XM, Zhang Y, He FC. Rapid induction of mRNAs for liver regeneration genes by hepatopoietin and partial hepatectomy. Zhonghua Gan Zang Bing Za Zhi 2002, 10:256-259.
36. Guardavaccaro D, Corrente G, Covone F, Micheli L, D'Agnano I, Starace G, Caruso M, Tirone F. Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol 2000, 20:1797-1815. 10.1128/MCB.20.5.1797-1815.2000, 85361, 10669755.
37. el-Ghissassi F, Valsesia-Wittmann S, Falette N, Duriez C, Walden PD, Puisieux A. BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells. Oncogene 2002, 21:6772-6778. 10.1038/sj.onc.1205888, 12360398.
38. Klopp AH, Jhingran A, Ramdas L, Story MD, Broadus RR, Lu KH, Eifel PJ, Buchholz TA. Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome. Int J Radiat Oncol Biol Phys 2008, 71:226-236.
39. Jin S, Tong T, Fan W, Fan F, Antinore MJ, Zhu X, Mazzacurati L, Li X, Petrik KL, Rajasekaran B, Wu M, Zhan Q. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene 2002, 21:8696-8704. 10.1038/sj.onc.1206034, 12483522.
40. Takekawa M, Saito H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 1998, 95:521-530. 10.1016/S0092-8674(00)81619-0, 9827804.
41. Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD, Haber DA. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 1999, 97:575-586. 10.1016/S0092-8674(00)80769-2, 10367887.